SpringWorks Therapeutics to Present Progress Across the
-- NDA filing for Nirogacestat in Desmoid Tumors, Which Will Be Reviewed Under the FDA’s Real-Time Oncology Review (RTOR) Program, Expected in Second Half...
Source: globenewswire.com
Program Update Jim Cassidy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Program Update Jim Cassidy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.